Biotech company ATAI Life Sciences plans to acquire $5 million BTC
2025-03-20 20:25:52
ATAI Life Sciences, a biopharmaceutical company, announced that it will adopt a bitcoin financial strategy and plans to invest an initial $5 million in bitcoin. Affected by the news, ATAI's share price briefly rose. Christian Angermayer, chairperson of the company, said that the company plans to invest an initial $5 million in bitcoin, while retaining sufficient cash, short-term securities and public equity to protect the company's operating funds until 2027.
Disclaimer:
1. The information provided does not constitute investment advice. Investors should make independent decisions and bear all risks themselves.
2. The copyright of this content belongs to the original author. The views expressed herein are solely those of the author and do not represent the stance or position of this website.
Previous article：
生物科技公司ATAI Life Sciences计划购入500万美元BTCNext article：
“新债王”冈拉克：美国经济陷入衰退的概率高于50%
